黄龙固本汤合舒利迭治疗支气管哮喘缓解期(肺肾两虚证)的临床研究  

Clinical Observation of Huanglong Guben Decoction Combined with Seretide on Bronchial Asthma of Lung and Kidney Deficiency Type in Remission Period

作　　者：钟骏慧[1] 彭文宏[1] 曾佳 

机构地区：[1]重庆市中医院,重庆400021

出　　处：《中国中医急症》2018年第1期72-73,93,共3页Journal of Emergency in Traditional Chinese Medicine

基　　金：重庆市卫计委中医药科技项目(ZY201402039)

摘　　要：目的观察黄龙固本汤与舒利迭联用治疗支气管哮喘缓解期的疗效。方法将150例患者按随机数字表法分为治疗组与对照组各75例,治疗组使用常规舒利迭联合黄龙固本汤,对照组单用舒利迭;疗程结束后比较疗效。结果治疗组临床控制率为77.33%,高于对照组的66.67%(P<0.05);两组患者治疗后肺功能较治疗前均有一定程度改善(P<0.05)。两组比较,治疗组肺功能VC、MVV%、FEV1等指标改善程度优于对照组(P<0.05)。结论黄龙固本汤合舒利迭治疗支气管哮喘缓解期疗效较好。Objective： To observe the effect of Huanglong Guben Decoction combined with Seretide on bronchial asthma in remission period. Methods： 150 patients were randomly divided into the treatment group and the control group,75 cases in each group. The treatment group used conventional Seretide and Huanglong Guben Decoction,while the control group was treated with only Seretide. The efficacy of the two groups was compared after the end of treatment. Results： The clinical control rate of the treatment group was 77.33% ,and the control group was 66.67% ,the difference between the two groups was statistically significant（P〈 0.05）. The lung function of the two groups was improved to some extent after treatment （P〈 0.05）. The improvement of lung function vc, MVV%,FEVI and other indexes in the treatment group was better than that in the control group（P〈 0.05）. Con- clusion： Huanglong Guben Decoction and Seretide have a better curative effect on bronchial asthma in remission period.

关 键 词：支气管哮喘 舒利迭 黄龙固本汤 

分 类 号：R562.25[医药卫生—呼吸系统]